NEW YORK, NY / ACCESS Newswire / October 28, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
ACCESSWIRE
NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance. The Company is now expecting ...
NEW YORK, NY / ACCESS Newswire / October 28, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of F5, Inc. ("F5, Inc.") (NASDAQ:FFIV) concerning possible violations of federal securities laws.F5 disclosed on October 15, 2025, that the company learned on August 9, 2025 "that a highly sophisticated nation-state threat actor had gained unauthorized access to certain [F5] systems." F5 further revealed that "[d]uring the course of its ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced ...
Did You Lose Money on WPP plc (WPP)? Levi & Korsinsky Urges Investors to Act Before December 8, 2025
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE LAWSUIT: ...
NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced ...
Purple Diamond Awards Gala Names OX_Agency and Xtrends.io as Official Media Sponsors, amplifying a Global Message of Hope and Resilience BLOOMFIELD, NJ / ACCESS Newswire / October 27, 2025 / The Black Fairy Godmother Foundation, founded by philanthropist Simone Gordon, proudly presents the 10th Annual Purple Diamond Awards Gala on Saturday, November 8, 2025, at Brookside Banquet, 41 Broughton Ave, Bloomfield, NJ. Powered by OX_Agency and Xtrends. This year's gala celebrates visionary ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance. The Company is now expecting ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Dow Inc. (NYSE:DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Western Alliance Bancorporation ("Western Alliance Bancorporation") (NYSE:WAL) concerning possible violations of federal securities laws.Western Alliance Bancorporation disclosed on October 16, 2025, that it had initiated a lawsuit against a borrower, Cantor Group V LLC, alleging fraud related to collateral loans.Following this news, Western Alliance ...
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arcturus Therapeutics Holdings Inc. ("Arcturus Therapeutics Holdings Inc.") (NASDAQ:ARCT) concerning possible violations of federal securities laws.Arcturus issued a press release on October 22, 2025, "announcing interim results from its ongoing Phase 2 clinical trial of ARCT-032, an investigational inhaled mRNA therapy for people with cystic ...